Meet us at CPHI Milan 2026

Borderless science. Exceptional client-centricity. Discover how Syngene is redefining CRDMO.

Your pipeline, our expertise. Let's talk!

Your molecule. Our expertise. From discovery to commercial.

Bring us your toughest challenge and we will move it faster from molecule to market. Syngene is your fully integrated partner across discovery, development, clinical research, and manufacturing for small, large and niche molecules. We go deep where the pipeline is heading, with proven expertise in antibody drug conjugates, peptides, and oligonucleotides. 

Backed by proven manufacturing excellence and a global network across India and the United States, you choose where to build and scale, with the supply chain resilience that protects your timelines and your patients. Meet us at CPHI Milan and see how  our science led, client centric partnership turns your ambition into commercial reality.

Siddharth Mittal

Chief Executive Officer

Abhijit Zutshi

Chief Commercial Officer

Andrew Setikas

Vice President
CDMO Services

Julien-Hugon

Julien Hugon

Vice President
CDMO Services

Manoj Babu

Vice President
CDMO Services

Rajkumar Agarwal

Associate Vice President
T&CR Services

Vivek Kumaravel

Associate Vice President
CDMO Services

Rajkumar Agarwal

Associate Vice President
T&CR Services

Mattias Nystrom

Senior Director
CDMO Services

Samantha Hullah

Vice President
CDMO Services

Vivek Sah

Associate Vice President
Marketing

Bichitra-Bhattacharya

Bichitra Bhattacharya

Director
TSS

Pramuch Goel

Head of Corporate Affairs

Sudhir Nambiar

Vice President, Drug Substance Development and Manufacturing

Purushottam Singnurkar

Vice President Pharmaceutical Development

Julien Hugon

Vice President, Business Development

Rajkumar Agarwal

General Manager,
Business Development

Manoj Babu

VP, Development Services

R&D and cGMP manufacturing facilities across the U.S. and India

Bayview, Maryland, U.S.
Mammalian  Manufacturing
16 KL (expandable)

Mangalore, India
SM CDMO API manufacturing
~70 KL (expandable)

Biocon Park , Bangalore, India
Mammalian, Microbial, SM API, DP OSD
LM CDMO: 8 KL
SM CDMO: ~70 KL

Unit 3, Bangalore, India
Mammalian, GMP Bioconjugation
LM CDMO: 22 KL (expandable)
DP: Vials, 2 lines, 500 vials/min

Hyderabad, India
India’s first automated compound management facility
R&D center for novel modalities including ADCs, TIDES and PROTACs

The Syngene Advantage

Quality Focus

We are a fully digitized quality organization with a strong compliance track record with global regulators. Our facilities are US FDA, EMA, and PMDA approved, GLP certified, and AAALAC accredited.

Sustainability

As part of our commitment to sustainability, we recycled 63% water, consumed 92% renewable energy, and recycled 95% waste. We had zero environmental violations, and we won the TIME Magazine award for being the most sustainable pharma company in India, and in the Top 20 globally. 

Green Chemistry Innovation

Implemented green chemistry across process design, process development, execution, and disposal phases. Also, reduced raw materials, solvents, waste, and disposal.

Robust Supply Chain

A network of 2500+ suppliers across 30+ countries, contracts with global partners, 24X7 local arrangements, and extended support to local partners. Plus, expanded biologics capabilities with our new facility in Bayview, Maryland, U.S.

Brochures

We look forward to meeting you in Fiera Milano, Italy.
Let’s shape the future of science together.

Syngene International Limited. All rights reserved © 2026